[SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19]. / Cibler la protéase majeure du SARS-CoV-2 pour fabriquer un médicament efficace contre ce coronavirus.
Med Sci (Paris)
; 36(6-7): 555-558, 2020.
Article
in French
| MEDLINE | ID: covidwho-611701
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Pneumonia, Viral
/
Protease Inhibitors
/
Coronavirus Infections
/
Betacoronavirus
Type of study:
Observational study
Limits:
Humans
Language:
French
Journal:
Med Sci (Paris)
Journal subject:
Medicine
Year:
2020
Document Type:
Article
Affiliation country:
Medsci
Similar
MEDLINE
...
LILACS
LIS